IP Verse

Drospirenone-Based Contraceptive For A Female Patient Affected With Excess Weight - EP3313408

The patent EP3313408 was granted to Laboratorios Leon Farma on Dec 6, 2023. The application was originally filed on Jun 23, 2016 under application number EP16731177A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3313408

LABORATORIOS LEON FARMA
Application Number
EP16731177A
Filing Date
Jun 23, 2016
Status
Granted And Under Opposition
Nov 3, 2023
Grant Date
Dec 6, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBSep 5, 2024ADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1746101
DESCRIPTIONUS4129564
DESCRIPTIONWO2006061309
DESCRIPTIONWO2012000981
DESCRIPTIONWO9806738
INTERNATIONAL-SEARCH-REPORTWO2012000981
OPPOSITIONWO2012000981
OPPOSITIONWO2016207298

Non-Patent Literature (NPL) Citations (39) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ABDOLLAHI M. ET AL., THROMB. HAEMOST, (2003), vol. 89, no. 3, pages 493 - 498-
DESCRIPTION- BELSEY ET AL., CONTRACEPTION, (198808), vol. 38, no. 2, pages 243 - 57-
DESCRIPTION- BLANCO-MOLINA MA ET AL., "Progestin-only contraception and venous thromboembolism", THROMBOSIS RESEARCH, (2012), vol. 129, pages E257 - E262-
DESCRIPTION- CASEY ET AL., CONTRACEPTION, (2013), vol. 87, pages 370 - 374-
DESCRIPTION- CEDERGREN MI., OBSTET. GYNECOL., (2004), vol. 103, pages 219 - 24-
DESCRIPTION- CONNOR ET AL., J. AM. BORAD FAM. PRACT., (2002), vol. 15, no. 1, pages 7 - 10-
DESCRIPTION- DRAGOMAN M. ET AL., CONTRACEPTION., (201304), vol. 87, no. 4, pages 432 - 436-
DESCRIPTION- FLEGAL ET AL., JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, (2012), vol. 307, no. 5, pages 491 - 97-
DESCRIPTION- FRASER IS ET AL., "Depo-Provera use in an Australian metropolitan practice", MED J AUSTRALIA, (1994), vol. 160, no. 9, pages 553 - 6-
DESCRIPTION- HAMPTON RM ET AL., CONTRACEPTION, (2008), vol. 77, no. 6, pages 415 - 419-
DESCRIPTION- HAREL Z ET AL., "Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.", J ADOLESC HEALTH, (1996), vol. 19, no. 2, pages 1 18 - 23-
DESCRIPTION- HILL DA., "Gynecology case challenge: vaginal bleeding in a woman taking an injectable contraceptive.", MEDSCAPE WOMENS HEALTH, (1998), vol. 3, no. 1, page 4-
DESCRIPTION- KAUNITZ AM, "Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians", INT J FERTIL WOMENS MED, (1998), vol. 43, no. 2, pages 73 - 83-
DESCRIPTION- KIRK ET AL., RAPID COMMUNICATION IN MASS SPECTROMETRY, (2006), vol. 20, pages 1247 - 1252-
DESCRIPTION- LIDEGAARD O. ET AL., 2001-9. BMJ, (2011), vol. 343, page D6423-
DESCRIPTION- MANTHA S ET AL., BMJ, (2012), vol. 345, page E4944-
DESCRIPTION- MISHELL ET AL., CONTRACEPTION, (2007), vol. 75, no. 1, page 11-
DESCRIPTION- MMWR Early Release, CENTERS FOR DISEASE CONTROL AND PREVENTION, (2010), vol. 59, pages 1 - 86-
DESCRIPTION- MURTHY AS., SEMIN REPROD MED., (201003), vol. 28, no. 2, pages 156 - 63-
DESCRIPTION- NUTLEY T ET AL., "Treatment of bleeding problems associated with progestin-only contraceptives: survey results.", ADV CONTRACEPT, (1997), vol. 13, no. 4, pages 419 - 28-
DESCRIPTION- POMP ER ET AL., BR J HAEMATOL, (2007), vol. 139, pages 289 - 296-
DESCRIPTION- ROSENBAUM ET AL., THE EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, (2000), vol. 5, pages 16 - 24-
DESCRIPTION- ROSENBERG MJ ET AL., J REPROD. MED., (1995), vol. 40, no. 5, pages 355 - 360-
DESCRIPTION- ROSENBERG M., "Weight change with oral contraceptive use and during the menstrual cycle: results of daily measurements", CONTRACEPTION, (1998), vol. 58, pages 345 - 9-
DESCRIPTION- SEDGH G. ET AL., STUDIES IN FAMILY PLANNING, (2014), vol. 45, no. 3, pages 301 - 314-
DESCRIPTION- SHIGETOH ET AL., AM. J. HYPERTENSION, (200902), vol. 22, no. 2, pages 151 - 155-
DESCRIPTION- CURTIS KM. ET AL., "Progestogen-only contraceptive use in obese women", CONTRACEPTION, (2009), vol. 80, no. 4, doi:doi:10.1016/j.contraception.2009.04.006, pages 346 - 354, XP026600651
DESCRIPTION- KEDER LM ET AL., "Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders", AM J OBSTET GYNECOL, (1998), vol. 179, doi:doi:10.1016/S0002-9378(98)70048-1, pages 583 - 5, XP005691438
INTERNATIONAL-SEARCH-REPORT- DINGER J C ET AL, "Oral contraceptive effectiveness according to body mass index, weight, age, and other factors", AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY, MOSBY, ST LOUIS, MO, US, vol. 201, no. 3, doi:10.1016/J.AJOG.2009.03.017, ISSN 0002-9378, (20090901), pages 263.e1 - 263.e9, (20090530), XP026557648 [A] 1-11 * the whole document *
INTERNATIONAL-SEARCH-REPORT- BLANCO-MOLINA M A ET AL, "Progestin-only contraception and venous thromboembolism", THROMBOSIS RESEARCH, TARRYTOWN, NY, US, vol. 129, no. 5, doi:10.1016/J.THROMRES.2012.02.042, ISSN 0049-3848, (20120222), pages e257 - e262, (20120229), XP028419802 [A] 1-11 * the whole document *
OPPOSITION- Anonymous, "Die östrogenfreie ovulationshemmende Pille - eine Alternative für viele Frauen", Journal für Gynäkologische Endokrinologie (Interview mit Prof. Dr. Bitzer), (20100101), vol. 4, no. 4, pages 53 - 54, XP093212591-
OPPOSITION- Bonnema Rachel A., Mcnamara Megan C., Spencer Abby L., "Contraception Choices in Women with Underlying Medical Conditions", AMERICAN FAMILY PHYSICIAN, American Academy of Family Physicians, US, US , (20100915), vol. 82, no. 6, ISSN 0002-838X, pages 621 - 628, XP093212595-
OPPOSITION- Kollmann Zahraa, Katja Wolf, "Kontrazeption bei Übergewicht und Adipositas - Die heutigen Optionen", GYNÄKOLOGIE, (20150101), vol. 1, XP093212593-
OPPOSITION- Dinger, J.C. ; Cronin, M. ; Mohner, S. ; Schellschmidt, I. ; Minh, T.D. ; Westhoff, C., "Oral contraceptive effectiveness according to body mass index, weight, age, and other factors", AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY, MOSBY, ST LOUIS, MO, US, US , (20090901), vol. 201, no. 3, doi:10.1016/j.ajog.2009.03.017, ISSN 0002-9378, pages 263.e1 - 263.e9, XP026557648
OPPOSITION- Richter W.H.; Koytchev R.; Kirkov V.; Merki G.; Colli E.; Regidor P.-A., "Comparative pharmacokinetic estimates of drospirenone alone and in combination with ethinyl estradiol after single and repeated oral administration in healthy females", CONTRACEPTION., GERON-X, INC., LOS ALTOS, CA., US, US , (20191121), vol. 101, no. 2, doi:10.1016/j.contraception.2019.10.005, ISSN 0010-7824, pages 137 - 143, XP086046600
OPPOSITION- Creinin Mitchell D., Angulo Alicyoy, Colli Enrico, Archer David F., "The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users", CONTRACEPTION., GERON-X, INC., LOS ALTOS, CA., US, US , (20231201), vol. 128, doi:10.1016/j.contraception.2023.110136, ISSN 0010-7824, page 110136, XP093212587
OPPOSITION- Mantha S., Karp R., Raghavan V., Terrin N., Bauer K. A., Zwicker J. I., "Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis", BMJ (CLINICAL RESEARCH ED.), British Medical Association, GB, GB , (20120807), vol. 345, no. aug07 2, doi:10.1136/bmj.e4944, ISSN 1756-1833, pages e4944 - e4944, XP093212584
OPPOSITION- De Melo Nilson Roberto, "Estrogen-Free Oral Hormonal Contraception: Benefits of the Progestin-Only Pill", WOMEN'S HEALTH, FUTURE MEDICINE,, UK, UK , (20100901), vol. 6, no. 5, doi:10.2217/WHE.10.36, ISSN 1745-5057, pages 721 - 735, XP093212589
OPPOSITION- Duijkers et al., "A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen", The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, Taylor & Francis Ltd, (20150615), vol. 20, no. 6, doi:10.3109/13625187.2015.1044082, ISSN 1473-0782, pages 419 - 427, XP009557542

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents